about
Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways.Lack of AcrB Efflux Function Confers Loss of Virulence on Salmonella enterica Serovar Typhimurium.Accumulation of norfloxacin by Bacteroides fragilis.Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.Exploiting the role of TolC in pathogenicity: identification of a bacteriophage for eradication of Salmonella serovars from poultry.Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.Metabolic constraints on the evolution of antibiotic resistance.Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance.Regulation of RamA by RamR in Salmonella enterica serovar Typhimurium: isolation of a RamR superrepressorExpression of homologous RND efflux pump genes is dependent upon AcrB expression: implications for efflux and virulence inhibitor design.RamA, which controls expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon proteaseCiprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolCThe TCA cycle is not required for selection or survival of multidrug-resistant Salmonella.Activity of antibiotics used in human medicine for Campylobacter jejuni isolated from farm animals and their environment in Lancashire, UK.Contribution of efflux to antibiotic resistance in Campylobacter isolated from poultry in Senegal.Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv.Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones.Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem.Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression.Persistence of Campylobacter species, strain types, antibiotic resistance and mechanisms of tetracycline resistance in poultry flocks treated with chlortetracycline.The multiple antibiotic resistance operon of enteric bacteria controls DNA repair and outer membrane integrity.CsrA maximizes expression of the AcrAB multidrug resistance transporter.Regulation of the AcrAB-TolC efflux pump in Enterobacteriaceae.Only for substrate antibiotics are a functional AcrAB-TolC efflux pump and RamA required to select multidrug-resistant Salmonella Typhimurium.Clinically Relevant Plasmid-Host Interactions Indicate that Transcriptional and Not Genomic Modifications Ameliorate Fitness Costs of Klebsiella pneumoniae Carbapenemase-Carrying Plasmids.Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis
P50
Q33415948-9B6F3E09-14AF-4222-A531-4E7B6F0C64CDQ33916492-0C011AF3-9641-4DA3-89DA-E60A55AD7C9AQ33980437-97C07D21-1515-4ADE-AE85-54FE901F595AQ35128319-BA13D860-C3D0-44C0-A8D1-5B54A754CEB1Q35212722-13A1E0D7-4641-462A-9F83-B1BDD3A6C397Q37074679-8E4A0C08-8BF4-48DD-9D75-545B29C50494Q39411172-69213057-7E4B-4288-87D8-C0CAD7E2EA52Q39559460-0241443F-50C1-4F53-B71D-273050CF402AQ40306067-DDFD4704-3056-44A9-96F2-1BAE9A301ED1Q40705905-14F9F818-B461-4750-85D0-956E3627716EQ41570607-CEF8C8C4-ECB9-45B7-933D-57146F42C576Q41713407-C4BECDD5-35D3-4179-83ED-0BD43A53336EQ41949884-AE8316A3-B34C-4A3F-B54B-3613F6F6EE89Q41988982-32E76039-EA24-401C-9671-9D621F28B928Q42776660-EB46E72C-9FF2-4E06-ACFB-FD9CCA4D5B1DQ43566624-504771CB-82E5-4BF8-95CA-1B70836D66D1Q43805820-AB501676-9657-41F5-9F14-78B15254633AQ43815734-215DCA91-A9AA-47C7-ADE1-F9332EB0084FQ44570681-76D93C72-26E9-4962-A178-AABF95BB80E9Q44980327-88B24878-6D25-4907-BA1E-2B1F7E12582CQ46546961-516F95A7-4AB9-4FC9-8A1E-17DB344C6878Q46604479-82A39995-2093-4C44-954E-C45BC4A36928Q47117249-FEB80D97-7A29-4DBB-BA30-B137F2682E67Q47120098-3CADE53D-1683-48AA-84CC-6DAD6C0CCFD6Q47613288-8CFF2944-EB9D-4371-BAD7-D2B704576283Q50054362-FC324350-12C3-46F4-8231-C4CDF3869539Q52310643-7D5D4257-17B3-4B44-BF51-33A9171A6938Q59486017-EE7D7135-868B-4B35-9EEE-BD8756E9AA02
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vito Ricci
@ast
Vito Ricci
@en
Vito Ricci
@es
Vito Ricci
@nl
type
label
Vito Ricci
@ast
Vito Ricci
@en
Vito Ricci
@es
Vito Ricci
@nl
prefLabel
Vito Ricci
@ast
Vito Ricci
@en
Vito Ricci
@es
Vito Ricci
@nl
P106
P31
P496
0000-0001-7621-8389